Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Management of Eclampsia

Immediate Seizure Management

  • The American College of Cardiology recommends magnesium sulfate as the definitive first-line anticonvulsant for eclamptic seizures, which must be administered immediately 1, 2

Urgent Blood Pressure Control

  • The American Heart Association recommends severe hypertension (≥160/110 mmHg) requires immediate treatment within 15 minutes to prevent maternal cerebral hemorrhage 1, 3
  • The American College of Obstetricians and Gynecologists recommends oral nifedipine as the preferred first-line agent for urgent blood pressure control 2, 4
  • Target systolic blood pressure should be 110-140 mmHg, and target diastolic blood pressure should be 85 mmHg 1, 2, 3

Comprehensive Laboratory Assessment

  • Complete blood count with hemoglobin and platelet count should be assessed for thrombocytopenia (<100,000/μL) 1, 3
  • Comprehensive metabolic panel, including AST/ALT, creatinine, and uric acid, should be evaluated for renal dysfunction and HELLP syndrome 1, 3

Maternal Monitoring Protocol

  • Continuous or every 4-hour blood pressure monitoring should be performed 4
  • Assess for visual disturbances, epigastric or right upper quadrant pain, and monitor for pulmonary edema 1

Fetal Assessment

  • Electronic fetal heart rate monitoring should be performed to assess fetal well-being 3, 4
  • Non-reassuring fetal status is an absolute indication for immediate delivery 1, 2, 4

Delivery Planning

  • Delivery is the definitive treatment for eclampsia and should occur after maternal stabilization 1
  • Immediate delivery is recommended for gestation ≥37 weeks after maternal stabilization 1, 2, 3

Critical Pitfalls to Avoid

  • Do not underestimate disease severity, as all eclampsia can rapidly progress to life-threatening complications 1, 3
  • Do not rely on blood pressure alone to determine severity, as serious organ dysfunction develops at relatively mild BP elevations 1, 3, 4

Special Considerations for HELLP Syndrome

  • HELLP syndrome carries 3.4% maternal mortality, and epigastric or right upper quadrant pain is the hallmark symptom 1

Management of Eclampsia

Maternal Monitoring and Treatment

  • The American College of Cardiology recommends continuing magnesium sulfate for 24 hours postpartum, as eclampsia can occur in the postpartum period, with a recurrence rate of 0.6% with magnesium vs 2% without 5, 6
  • Monitoring should include blood pressure at least every 4-6 hours for at least 3 days postpartum, and neurological monitoring, as postpartum eclampsia remains a risk 5, 6
  • Fluid balance should be limited to 60-80 mL/hour to avoid pulmonary edema, with a target urine output of 0.5-1 mL/kg/hour 5, 6

Postpartum Care

  • The American College of Cardiology recommends monitoring BP at least every 4-6 hours for at least 3 days postpartum, and continuing neurological monitoring, as postpartum eclampsia remains a risk 5
  • Repeat laboratory tests (hemoglobin, platelets, creatinine, liver enzymes) should be done the day after delivery and then every other day until stable 5
  • NSAIDs should be avoided for postpartum analgesia in women with eclampsia, especially in the setting of renal dysfunction, as they can worsen hypertension and renal function 5, 6

Avoid Routine Plasma‑Volume Expansion in Eclampsia Management

Critical Management Considerations

  • Routine administration of plasma‑volume expanders (e.g., crystalloid or colloid boluses) should be avoided in the treatment of eclampsia because it does not improve maternal outcomes and may exacerbate complications associated with pre‑eclamptic plasma‑volume contraction. 7